Viatris(US:VTRS) Prnewswireยท2025-08-07 10:59Core Viewpoint - Viatris Inc. reported strong second quarter 2025 financial results, reaffirming its 2025 financial guidance across all metrics, reflecting the resilience of its diversified global business and progress in its late-stage pipeline [1][5][11]. Financial Performance - Total revenues for Q2 2025 were $3.582 billion, a decrease of 6% year-over-year, while adjusted operational revenues decreased by 2% [4][11]. - Total net sales were $3.569 billion, down 6% from $3.786 billion in Q2 2024 [4][11]. - Developed markets saw a 9% decline in sales, while emerging markets experienced a 4% decline [4][11]. - Greater China reported a 9% increase in sales, indicating strong performance in that region [4][11]. - U.S. GAAP net loss was $4.6 million, a significant improvement from a loss of $326.4 million in Q2 2024 [4][11]. Operational Highlights - Adjusted EBITDA for Q2 2025 was $1.079 billion, down 11% year-over-year, while adjusted EPS was $0.62, a decrease of 10% [4][11]. - The company generated approximately $79 million in new product revenues during the quarter [11]. - Free cash flow for Q2 2025 was $167 million, down 48% from $320.3 million in Q2 2024 [4][12]. Capital Allocation - Year-to-date, Viatris returned over $630 million to shareholders, including $350 million in share buybacks [5][13]. - The company expects total share repurchases in 2025 to be between $500 million and $650 million [13]. Strategic Focus - The company is focused on driving commercial execution and investing in strategic business development opportunities to position itself for sustainable growth in 2026 and beyond [2][5]. - Viatris is pursuing regional licensing and partnership opportunities that contribute immediate revenue and leverage its commercial and R&D capabilities [14]. 2025 Financial Guidance - Viatris reaffirmed its 2025 financial guidance, estimating total revenues between $13.5 billion and $14 billion, with a midpoint of $13.75 billion [16][17]. - Adjusted EBITDA is expected to be between $3.89 billion and $4.19 billion, with adjusted EPS projected between $2.16 and $2.30 [16][17].